Impact of COVID-19 pandemic on antidepressants consumptions by wastewater analysis in Turkey


Güzel E. , Atasoy A., Gören İ. E. , Dağlıoğlu N.

SCIENCE OF THE TOTAL ENVIRONMENT, vol.838, 2022 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 838
  • Publication Date: 2022
  • Doi Number: 10.1016/j.scitotenv.2022.155916
  • Title of Journal : SCIENCE OF THE TOTAL ENVIRONMENT
  • Keywords: Wastewater-based epidemiology (WBE), COVID-19, Antidepressants, Drug consumption rate changes, CLINICAL PHARMACOKINETICS, AMITRIPTYLINE, METABOLISM, IMIPRAMINE, CLOMIPRAMINE, MIRTAZAPINE, VENLAFAXINE, EXCRETION, URINE

Abstract

The COVID-19 pandemic has been a major challenge worldwide, forcing countries to take restrictive measures beyond conventional methods in their fight against the spread of the disease. Followingly, many studies have been conducted on the effects of these measures on mental health. Wastewater-based epidemiology (WBE) was used in this study to monitor and estimate changes in antidepressant use under normal conditions (2019) and COVID-19 pandemic condi-tions (2020). Likewise, this study utilized wastewater-based epidemiology (WBE) to monitor and assess changing trends from the pre-pandemic period (2019) to COVID-19 pandemic conditions in antidepressant use (2020).Wastewater samples were collected from 11 cities in Turkey throughout six sampling periods covering the pre-pandemic and during-pandemic periods (June 2019-December 2020). Then, samples were analyzed via LC-MS/MS method. As a result, we observed that venlafaxine was the drug with the highest concentration (mean +/- SD: 103.6 +/- 112.1 mg/1000p/day). Moreover, city number 6 presented the highest venlafaxine use and the most dramatic in-crease during the pandemic period. Finally, this study revealed the potential of WBE to estimate the changing trends in mental health during the ongoing pandemic.